-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GvGY2xDoSMSX7pWNR8vh+tSZGcPYasIYaQ6itIwEiljeRZOAFp4bIExcbjcwNTOi eMh5HfFQ0FZy5td2A+CAUw== 0000936392-97-000131.txt : 19970221 0000936392-97-000131.hdr.sgml : 19970221 ACCESSION NUMBER: 0000936392-97-000131 CONFORMED SUBMISSION TYPE: 8-A12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970210 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE DIAGNOSTICS INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 97523170 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 8-A12G 1 FORM 8-A 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 BIOSITE DIAGNOSTICS INCORPORATED (Exact name of registrant as specified in its charter) Delaware 33-0288606 (State of incorporation (I.R.S. Employer or organization) Identification No.) 11030 Roselle Street, San Diego, California 92121 (Address of principal executive offices) (Zip Code) Securities to be registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which to be so registered each class is to be registered - ------------------- ------------------------------ None None If this Form relates to the registration of a class of debt securities and is effective upon filing pursuant to General Instruction A.(c)(1), please check the following box. / / If this Form relates to the registration of a class of debt securities and is to become effective simultaneously with the effectiveness of a concurrent registration statement under the Securities Act of 1933 pursuant to General Instruction A.(c)(2), please check the following box. / / Securities to be registered pursuant to Section 12(g) of the Act: Common Stock, $.01 par value per share (Title of class) 2 Item 1. Description of Registrant's Securities to be Registered. In response to this item, incorporated by reference is the description of the Common Stock, $.01 par value per share (the "Common Stock"), of Biosite Diagnostics Incorporated (the "Registrant") contained under the caption "Description of Capital Stock" in the Prospectus (Subject to Completion) dated February 10, 1997 that forms a part of the Registrant's Registration Statement on Form S-1 (File No. 333-17657) (the "Registration Statement"). Item 2. Exhibits. The following exhibits are filed as a part of this Registration Statement: 1(a)* Restated Certificate of Incorporation as filed with the Delaware Secretary of State on November 25, 1992 (incorporated by reference to Exhibit 3.(i)1 of the Registration Statement). 1(b)* Certificate of Amendment of Restated Certificate of Incorporation as filed with the Delaware Secretary of State on February 5, 1997 (incorporated by reference to Exhibit 3.(i)2 of the Registration Statement). 1(c)* Form of Restated Certificate of Incorporation to be filed upon closing of the offering to which the Registration Statement relates (incorporated by reference to Exhibit 3.(i)3 of the Registration Statement). 2(a)* Bylaws of the Registrant, as amended (incorporated by reference to Exhibit 3.(ii)1 of the Registration Statement). 2(b)* Proposed Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.(ii)2 of the Registration Statement). 3* Form of Common Stock Certificate of the Registrant (incorporated herein by reference to Exhibit 4.1 of the Registration Statement). 3 4 The description of the Common Stock of the Registrant contained under the caption "Description of Capital Stock" set forth on page 56 of the Prospectus (Subject to Completion) dated February 10, 1997 is incorporated by reference herein from the Registration Statement. * Filed as an exhibit to the Registration Statement or subsequent amendments thereto. 4 SIGNATURE Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereto duly authorized. Dated: February 10, 1997. BIOSITE DIAGNOSTICS INCORPORATED By /s/ Kim D. Blickenstaff ----------------------------- Kim D. Blickenstaff President and Chief Executive Officer 5 INDEX TO EXHIBITS
Sequentially Exhibit Numbered Number Exhibit Page - ------ ------- ---- 1(a)* Restated Certificate of Incorporation as filed with the Delaware Secretary of State on November 25, 1992 (incorporated by reference to Exhibit 3.(i)1 to the Registration Statement). 1(b)* Certificate of Amendment of Restated Certificate of Incorporation as filed with the Delaware Secretary of State on February 5, 1997 (incorporated by reference to Exhibit 3.(i)2 of the Registration Statement). 1(c)* Form of Restated Certificate of Incorporation to be filed upon closing of the offering to which the Registration Statement relates (incorporated by reference to Exhibit 3.(i)3 of the Registration Statement). 2(a)* Bylaws of the Registrant, as amended (incorporated by reference to Exhibit 3(ii).1 to the Registration Statement). 2(b)* Proposed Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.(ii)2 of the Registration Statement). 3* Form of Common Stock Certificate of the Registrant (incorporated herein by reference to Exhibit 4.1 of the Registration Statement). 4 The description of the Common Stock of the Registrant contained under the caption "Description of Capital Stock" set forth on page 56 of the Prospectus (Subject to Completion) dated February 10, 1997 is incorporated by reference herein from the Registration Statement.
* Filed as an exhibit to the Registration Statement or subsequent amendments thereto. -----END PRIVACY-ENHANCED MESSAGE-----